Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Filed with BSE · ISIN INE354A01013 · · 4 pages · English
Jenburkt Pharmaceuticals Ltd on 6ix
Story so far
Earlier from Jenburkt Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Board Meeting Intimation for Considering And Approving Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September, 2026.
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Jenburkt Pharmaceuticals Ltd Press Release Sep 04 2026
Follow Jenburkt Pharmaceuticals into a list and get an email when it puts out news.
Follow Jenburkt Pharmaceuticals